Mortality Increased With Delayed Admission for Patients With Hip Fracture
By Elana Gotkine HealthDay Reporter
THURSDAY, Oct. 10, 2024 -- For patients with hip fracture, delayed admission is associated with increased mortality risk, according to a study published online Oct. 8 in Emergency Medicine Journal.
Nicholas D. Clement, M.B.B.S., M.D., Ph.D., from the Royal Infirmary of Edinburgh in the United Kingdom, and colleagues undertook a single-center evaluation involving patients aged older than 50 years who were admitted to a Scottish hospital through the emergency department with a hip fracture from January 2019 to June 2022 to examine the impact of delayed admission, defined as spending more than four hours in the emergency department from arrival.
The cohort included 3,266 patients (mean age, 81 years); 38.6 percent had delayed admission. The researchers identified 1,314 deaths (40.2 percent) during a median follow-up of 529 days. Survival at 90 days was significantly lower for patients with versus without delayed admission (92.9 versus 95.7 percent; hazard ratio, 0.76). There was an independent association for delayed disposition with increased mortality risk at 90 days and final follow-up (adjusted hazard ratios, 1.36 and 1.15, respectively). There was also an association for delay with longer length of hospital stay (difference in medians of one day). No differences were seen in the risk for delirium on the ward or return to place of residence.
"There was an association between emergency department waiting time and poorer hip fracture outcomes," the authors write. "Adoption of emergency department-accelerated care pathways in our institution may help improve their outcomes."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Posted October 2024
Read this next
Sodium-Glucose Cotransporter 2 Inhibitors Increase Risk for Falls in Patients With Diabetes
WEDNESDAY, April 30, 2025 -- Sodium-glucose cotransporter 2 (SGLT2) inhibitor use is an independent risk factor for falls in people with type 2 diabetes, according to a study...
Study IDs Predictors of Biomechanical Function in Patients With OA Undergoing Hip Replacement
WEDNESDAY, April 23, 2025 -- For patients undergoing total hip arthroplasty (THA), osteoarthritis (OA) severity is the best predictor of preoperative biomechanical function, and...
Birmingham Hip Resurfacing Safe, Effective Over 15 Years
MONDAY, April 21, 2025 -- Birmingham hip resurfacing (BHR) is effective and shows implant longevity in appropriately selected patients, according to a study published in the March...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.